It was a week of accolades, partnerships and new programs in the Pacific Northwest life sciences scene. University of Washington geneticist Evan Eichler landed on Time magazine’s list of “100… Read More
When Juno Therapeutics launched in 2013, cell therapy was a nascent field. Early clinical studies were showing dramatic rates of remissions in leukemia patients treated with their own immune cells,… Read More
New funding: Just seven months after announcing a $53 million Series A round, Umoja Biopharma has raised an additional $210 million in a Series B round. The company is developing… Read More